Lumos Pharma Inc (NASDAQ:LUMO)

Delayed Data
As of Apr 06
 +1.03 / +13.24%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Lumos Pharma Inc have a median target of 36.00, with a high estimate of 36.00 and a low estimate of 36.00. The median estimate represents a +304.27% increase from the last price of 8.90.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in Lumos Pharma Inc. This rating has held steady since June, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
Growthannually 80.87%


Growthquarterly --
Growthannually 4,974.79%
Key to the earnings and sales forecast charts.